Healthcare & Life Sciences News and Articles

Google News – EMA (biotech/pharma) External News

EU pharma regulators publish annual AI observatory report - Osborne Clarke

news.google.com · 31 Jul 2026

Google News – EMA (biotech/pharma) External News

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate - finance.yahoo.com

news.google.com · 30 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA Proposal May Drastically Extend Pharma TV Ad Length - The Capitol Forum

news.google.com · 30 Jul 2026

Google News – FDA (biotech/pharma) External News

Pharmalittle: We're reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more - STAT

news.google.com · 30 Jul 2026

Google News – FDA (biotech/pharma) External News

Press Release Service: Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia - CRISPR Medicine News

news.google.com · 30 Jul 2026

Google News – FDA (biotech/pharma) External News

What Needs to Be True for the FDA's Real-Time Pilot Model to Work Beyond Big Pharma - Applied Clinical Trials Online

news.google.com · 29 Jul 2026

Google News – Biotech Funding External News

UK biotech venture investment hits five-year high - Healthcare Today

news.google.com · 29 Jul 2026

Industry News External News

China biotech sector fears policy backlash after girl dies in gene-editing trial - South China Morning Post

news.google.com · 29 Jul 2026

Google News – FDA (biotech/pharma) External News

Capricor Duchenne cell therapy voted down by FDA panel - BioPharma Dive

news.google.com · 29 Jul 2026

Google News – Biotech Funding External News

12 Funding Rounds That Show Where APAC Biotech Capital Is Going - BioPharma APAC

news.google.com · 29 Jul 2026

Google News – EMA (biotech/pharma) External News

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Business Wire

news.google.com · 28 Jul 2026

Google News – FDA (biotech/pharma) External News

How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval - Fierce Pharma

news.google.com · 28 Jul 2026

Google News – EMA (biotech/pharma) External News

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - BioSpace

news.google.com · 28 Jul 2026

Google News – Digital Health External News

FDA Announces Funding Opportunity for Research on Digital Health Technologies in Drug and Biologic Development - Wilson Sonsini

news.google.com · 28 Jul 2026

Google News – EMA (biotech/pharma) External News

Lantern Pharma’s bladder cancer trial cleared by EMA - Investing.com

news.google.com · 28 Jul 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

EU pharma regulators publish annual AI observatory report - Osborne Clarke

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate - finance.yahoo.com

FDA Proposal May Drastically Extend Pharma TV Ad Length - The Capitol Forum

Pharmalittle: We're reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more - STAT

Press Release Service: Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia - CRISPR Medicine News

What Needs to Be True for the FDA's Real-Time Pilot Model to Work Beyond Big Pharma - Applied Clinical Trials Online

UK biotech venture investment hits five-year high - Healthcare Today

China biotech sector fears policy backlash after girl dies in gene-editing trial - South China Morning Post

Capricor Duchenne cell therapy voted down by FDA panel - BioPharma Dive

12 Funding Rounds That Show Where APAC Biotech Capital Is Going - BioPharma APAC

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Business Wire

How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval - Fierce Pharma

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - BioSpace

FDA Announces Funding Opportunity for Research on Digital Health Technologies in Drug and Biologic Development - Wilson Sonsini

Lantern Pharma’s bladder cancer trial cleared by EMA - Investing.com